| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |